Summit Therapeutics (SMMT) announced on Tuesday that it has commenced an underwritten public offering of $500M of shares of its common stock. Shares of SMMT slipped over 9% in extended trading on ...
Share on Facebook (opens in a new window) Share on X (opens in a new window) Share on Reddit (opens in a new window) Share on Hacker News (opens in a new window) Share on Flipboard (opens in a new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results